Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 06 04:00PM ET
137.20
Dollar change
-1.16
Percentage change
-0.84
%
IndexS&P 500 P/E28.43 EPS (ttm)4.83 Insider Own0.40% Shs Outstand292.12M Perf Week-3.74%
Market Cap39.42B Forward P/E24.26 EPS next Y5.66 Insider Trans-6.84% Shs Float286.18M Perf Month2.42%
Income1.41B PEG5.69 EPS next Q1.41 Inst Own93.46% Short Float1.00% Perf Quarter3.30%
Sales6.50B P/S6.07 EPS this Y-3.74% Inst Trans-3.35% Short Ratio1.47 Perf Half Y-8.11%
Book/sh20.53 P/B6.68 EPS next Y8.01% ROA13.04% Short Interest2.86M Perf Year16.33%
Cash/sh6.19 P/C22.16 EPS next 5Y5.00% ROE24.66% 52W Range96.80 - 155.35 Perf YTD-1.32%
Dividend Est.0.94 (0.68%) P/FCF27.82 EPS past 5Y33.93% ROI17.57% 52W High-11.68% Beta1.05
Dividend TTM0.93 (0.68%) Quick Ratio1.37 Sales past 5Y7.00% Gross Margin54.84% 52W Low41.74% ATR (14)3.05
Dividend Ex-DateJul 02, 2024 Current Ratio1.78 EPS Y/Y TTM26.31% Oper. Margin24.49% RSI (14)45.76 Volatility2.36% 1.93%
Employees18100 Debt/Eq0.50 Sales Y/Y TTM-7.11% Profit Margin21.75% Recom2.41 Target Price147.17
Option/ShortYes / Yes LT Debt/Eq0.36 EPS Q/Q157.53% Payout21.48% Rel Volume0.67 Prev Close138.36
Sales Surprise1.32% EPS Surprise4.85% Sales Q/Q-5.62% EarningsAug 21 AMC Avg Volume1.95M Price137.20
SMA20-1.56% SMA501.35% SMA2000.38% Trades Volume1,297,513 Change-0.84%
Date Action Analyst Rating Change Price Target Change
Aug-28-24Initiated Wells Fargo Overweight $157
Jul-10-24Upgrade Citigroup Neutral → Buy $135 → $150
Jun-27-24Downgrade Wolfe Research Outperform → Peer Perform
Jun-03-24Resumed Jefferies Hold $135
Apr-05-24Upgrade Stifel Hold → Buy $145 → $163
Dec-13-23Initiated Wolfe Research Outperform $140
Dec-12-23Downgrade BofA Securities Buy → Neutral $130 → $133
Nov-17-23Downgrade UBS Buy → Neutral $163 → $125
Sep-28-23Initiated Bernstein Mkt Perform $123
Jul-31-23Downgrade Evercore ISI Outperform → In-line $126 → $124
Sep-02-24 07:33AM
Aug-31-24 01:04AM
Aug-28-24 09:34AM
Aug-26-24 09:15AM
Aug-23-24 03:00PM
12:50PM Loading…
Aug-22-24 12:50PM
09:51AM
Aug-21-24 09:28PM
08:53PM
06:00PM
05:15PM
04:13PM
04:05PM
Aug-20-24 10:29AM
09:01AM
10:18AM Loading…
Aug-19-24 10:18AM
Aug-18-24 02:00PM
Aug-16-24 09:15AM
Aug-15-24 08:00AM
Aug-14-24 10:00AM
Aug-12-24 12:58PM
Aug-02-24 08:00AM
Jul-31-24 07:25PM
Jul-30-24 01:01PM
Jul-29-24 09:55AM
Jul-26-24 03:35PM
Jul-25-24 04:09PM
Jul-24-24 07:24AM
Jul-23-24 06:33AM
Jul-22-24 11:19AM
10:47AM Loading…
10:47AM
09:01AM
Jul-21-24 09:12PM
Jul-19-24 08:46AM
Jul-16-24 04:01PM
Jul-13-24 12:05PM
Jul-01-24 01:04PM
09:01AM
Jun-28-24 11:30AM
Jun-27-24 12:06PM
09:48AM
Jun-26-24 10:07AM
Jun-21-24 03:10AM
Jun-14-24 06:54AM
Jun-06-24 12:01PM
Jun-03-24 11:27AM
11:00AM
May-31-24 07:34PM
May-30-24 04:24PM
02:36PM
12:15PM
11:58AM
11:34AM
07:47AM
07:39AM
07:34AM
06:38AM
May-29-24 08:53PM
06:00PM
05:15PM
04:14PM
04:05PM
May-28-24 11:44AM
May-26-24 07:00AM
May-23-24 04:05PM
09:15AM
08:04AM
May-22-24 04:05PM
10:00AM
08:00AM
May-17-24 02:30PM
May-16-24 10:59AM
08:00AM
May-13-24 09:30AM
May-02-24 04:53PM
12:10PM
11:45AM
09:30AM
May-01-24 10:31AM
08:45AM
08:00AM
Apr-29-24 08:45AM
Apr-18-24 04:30PM
Apr-16-24 08:00AM
Apr-15-24 08:00AM
Apr-09-24 11:37PM
12:02PM
10:41AM
Apr-05-24 09:55AM
Apr-04-24 08:00AM
Apr-03-24 08:00AM
Apr-02-24 11:15AM
08:00AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-28-24 11:30AM
Mar-27-24 05:01PM
Mar-26-24 02:00AM
Mar-14-24 08:00AM
Mar-12-24 05:00PM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCDONNELL PADRAIGPresident and CEOAug 22 '24Sale145.001,958283,91024,118Aug 23 11:43 AM
MCDONNELL PADRAIGOfficerAug 22 '24Proposed Sale145.001,958283,910Aug 22 12:39 PM
MCDONNELL PADRAIGPresident and CEOJul 26 '24Sale140.001,958274,12026,076Jul 30 10:42 AM
MCDONNELL PADRAIGOfficerJul 26 '24Proposed Sale140.001,958274,120Jul 26 10:56 AM
MCDONNELL PADRAIGPresident and CEOJun 18 '24Sale135.001,958264,33028,034Jun 20 06:54 PM
Grau DominiqueSenior Vice PresidentJun 10 '24Sale133.2815,0001,999,26249,486Jun 12 10:40 AM
MCDONNELL PADRAIGPresident and CEOJun 03 '24Sale130.001,958254,54025,185Jun 05 10:08 AM
Binns PhilipSenior Vice PresidentMar 25 '24Sale147.542,827417,0969,997Mar 27 01:29 PM
McMullen Michael R.CEO and PresidentMar 08 '24Sale150.0052,2977,844,550253,909Mar 12 02:37 PM
Gonsalves RodneyV.P., Corporate ControllerMar 07 '24Sale149.004,828719,34821,329Mar 08 12:05 PM
FIELDS HEIDIDirectorMar 05 '24Sale144.341,658239,31654,976Mar 07 10:38 AM
Binns PhilipSenior Vice PresidentDec 27 '23Sale139.782,880402,56612,824Dec 28 01:46 PM
Gonsalves RodneyV.P., Corporate ControllerDec 18 '23Sale137.691,500206,53826,133Dec 19 02:34 PM
Ancher-Jensen HenrikSr Vice PresidentDec 15 '23Option Exercise111.3611,7031,303,235108,835Dec 19 02:33 PM
Ancher-Jensen HenrikSr Vice PresidentDec 15 '23Sale138.3626,3313,643,15782,504Dec 19 02:33 PM
McMullen Michael R.CEO and PresidentDec 13 '23Option Exercise42.122,751115,872308,957Dec 15 05:08 PM
McMullen Michael R.CEO and PresidentDec 13 '23Sale130.002,751357,630306,206Dec 15 05:08 PM
McMullen Michael R.CEO and PresidentDec 07 '23Option Exercise42.1262,4672,631,110368,673Dec 08 02:59 PM
McMullen Michael R.CEO and PresidentDec 07 '23Sale130.0062,4678,120,710306,206Dec 08 02:59 PM
Gonsalves RodneyV.P., Corporate ControllerSep 28 '23Buy111.09328824,222Sep 29 04:03 PM
Last Close
Sep 06 04:00PM ET
18.09
Dollar change
-0.07
Percentage change
-0.39
%
ATLO Ames National Corp. daily Stock Chart
IndexRUT P/E17.03 EPS (ttm)1.06 Insider Own1.81% Shs Outstand8.99M Perf Week-3.21%
Market Cap162.63M Forward P/E- EPS next Y- Insider Trans1.51% Shs Float8.83M Perf Month-0.55%
Income9.55M PEG- EPS next Q- Inst Own26.29% Short Float0.83% Perf Quarter-11.19%
Sales88.71M P/S1.83 EPS this Y- Inst Trans7.54% Short Ratio4.51 Perf Half Y-2.90%
Book/sh18.58 P/B0.97 EPS next Y- ROA0.44% Short Interest0.07M Perf Year1.17%
Cash/sh- P/C- EPS next 5Y- ROE5.92% 52W Range15.01 - 22.50 Perf YTD-15.23%
Dividend Est.- P/FCF13.97 EPS past 5Y-8.02% ROI3.78% 52W High-19.60% Beta0.55
Dividend TTM1.08 (5.97%) Quick Ratio- Sales past 5Y8.01% Gross Margin- 52W Low20.52% ATR (14)0.68
Dividend Ex-DateNov 01, 2024 Current Ratio0.21 EPS Y/Y TTM-39.20% Oper. Margin12.73% RSI (14)44.09 Volatility2.62% 3.21%
Employees273 Debt/Eq0.76 Sales Y/Y TTM14.30% Profit Margin10.77% Recom- Target Price-
Option/ShortYes / Yes LT Debt/Eq0.51 EPS Q/Q-14.59% Payout89.78% Rel Volume0.36 Prev Close18.16
Sales Surprise1.26% EPS Surprise37.00% Sales Q/Q11.31% Earnings- Avg Volume16.36K Price18.09
SMA20-1.71% SMA50-7.45% SMA200-8.61% Trades Volume5,816 Change-0.39%
Aug-09-24 02:20PM
Jun-24-24 09:53AM
Apr-04-24 08:52AM
Jan-19-24 04:31PM
Dec-13-23 09:45AM
10:43PM Loading…
Aug-31-23 10:43PM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
06:44AM Loading…
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 07:12AM
06:05AM
Jul-21-23 07:23AM
Jul-20-23 06:55AM
Jul-19-23 07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
Jul-13-23 07:02AM
Jul-12-23 07:22AM
06:08AM Loading…
Jul-11-23 06:08AM
Jul-10-23 06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 06:58AM
Jun-27-23 06:46AM
Jun-26-23 06:41AM
Jun-23-23 09:24AM
Jun-22-23 07:05AM
Jun-21-23 07:05AM
Jun-20-23 06:35AM
Jun-15-23 06:38AM
Jun-14-23 06:39AM
Jun-13-23 06:37AM
Jun-12-23 06:47AM
Jun-09-23 06:34AM
Jun-08-23 06:43AM
Jun-07-23 08:25AM
Jun-06-23 06:34AM
Jun-05-23 06:44AM
Jun-01-23 07:06AM
May-25-23 06:38AM
May-24-23 06:43AM
May-22-23 07:49AM
May-19-23 07:03AM
May-18-23 07:03AM
May-10-23 03:41PM
Apr-23-23 08:28AM
Apr-05-23 06:38AM
Mar-17-23 06:38AM
Jan-26-23 05:37AM
Jan-23-23 05:19AM
Jan-20-23 04:30PM
Jan-16-23 06:43AM
Oct-27-22 06:51AM
Oct-01-22 04:06PM
Sep-30-22 04:23PM
Jul-24-22 08:26AM
Jul-02-22 08:50AM
Mar-11-22 12:39PM
Feb-15-22 04:09AM
Jan-23-22 06:24AM
Dec-13-21 09:07AM
Oct-26-21 08:12AM
Oct-25-21 06:02AM
Oct-22-21 06:38AM
Jul-24-21 03:26AM
Jul-23-21 03:22PM
01:45AM
Jun-13-21 01:06PM
Apr-24-21 03:21AM
Apr-23-21 01:23AM
Mar-09-21 12:06AM
Dec-09-20 11:11AM
Nov-29-20 08:26PM
Oct-24-20 09:57AM
Sep-15-20 11:22AM
Jul-26-20 10:40AM
May-31-20 05:37PM
Apr-25-20 08:00AM
Mar-15-20 08:34AM
Jan-24-20 05:38AM
Dec-22-19 01:52PM
Dec-10-19 06:17AM
Oct-26-19 07:55AM
Oct-22-19 06:34AM
Sep-10-19 02:58PM
Jul-26-19 02:18PM
Ames National Corp. is a bank holding company, which engages in the provision of banking services through its subsidiaries. Its activities include personal, business, agricultural and commercial lending, management of the investment securities portfolio, deposit account services, and wealth management services. The company was founded on January 21, 1975 and is headquartered in Ames, IA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baker Jeffery CDirectorSep 05 '24Buy18.1660010,8962,822Sep 06 09:14 AM
BAUDLER HORRAS BETTY ADirectorSep 04 '24Buy18.005090022,075Sep 05 12:21 PM
Cassabaum Michelle RDirectorAug 30 '24Buy18.752875,3816,868Sep 03 12:02 PM
Wilson Michael AExecutive Vice PresidentAug 22 '24Buy17.712003,542700Aug 23 01:44 PM
BAUDLER HORRAS BETTY ADirectorAug 07 '24Buy17.905089522,025Aug 08 11:40 AM
Snodgrass AdamPresident of subsidiary bankAug 02 '24Buy18.682003,736847Aug 07 05:15 PM
Cassabaum Michelle RDirectorAug 02 '24Buy19.351663,2126,581Aug 07 10:45 AM
BAUDLER HORRAS BETTY ADirectorAug 06 '24Buy18.405092021,975Aug 07 09:13 AM
BAUDLER HORRAS BETTY ADirectorAug 05 '24Buy18.345091721,925Aug 06 11:02 AM
Bauer Scott TPresident of subsidiary bankAug 02 '24Buy19.182003,8363,589Aug 02 12:38 PM
Hagan Patrick GDirectorAug 02 '24Buy19.252003,8507,170Aug 02 11:38 AM
Cassabaum Michelle RDirectorMay 31 '24Buy20.652976,1336,415May 31 04:50 PM
Cassabaum Michelle RDirectorApr 30 '24Buy19.50671,3066,118May 01 09:32 AM
Cassabaum Michelle RDirectorMar 01 '24Buy18.803005,6406,051Mar 04 03:07 PM
LARSON JAMES R IIDirectorFeb 07 '24Buy18.202504,55012,000Feb 07 12:14 PM
LARSON JAMES R IIDirectorFeb 06 '24Buy18.602504,65011,750Feb 06 03:39 PM
LARSON JAMES R IIDirectorFeb 02 '24Buy19.672003,93511,500Feb 05 10:27 AM
Cassabaum Michelle RDirectorJan 31 '24Buy21.86571,2465,751Feb 01 09:31 AM
Cassabaum Michelle RDirectorNov 30 '23Buy18.413105,7075,454Nov 30 01:17 PM
PUTZIER JEFFREY KPresident of subsidiary bankNov 20 '23Buy19.052003,8103,427Nov 21 09:40 AM
Bauer Scott TPresident of subsidiary bankOct 27 '23Buy16.103004,8303,389Oct 31 12:21 PM
NELSON JOHN PATRICKPresidentOct 27 '23Buy16.171,23720,00215,757Oct 31 12:17 PM
Cassabaum Michelle RDirectorOct 31 '23Buy16.75941,5745,144Oct 31 12:13 PM
Hagan Patrick GDirectorSep 15 '23Buy17.862003,5726,970Sep 15 03:49 PM
Swartz Kevin LDirectorSep 14 '23Buy17.805008,9004,780Sep 15 03:43 PM
BAUDLER HORRAS BETTY ADirectorSep 08 '23Buy17.831001,78321,875Sep 08 12:17 PM